Continue To Site >
Quicklinks
  • Ask Whole Foods Mag
  • Magazine Subscription
  • View Back Issues
  • Advertise
  • Education Center
  • Ashwagandha / Shatavari Experience
  • Naturally Informed
  • Move Nutrition
  • India-America Boardroom Series
Free Newsletter Subscription
Ask WholeFoods Mag
  • News
    • All News
    • In Case You Missed It
    • Breaking News
    • Grocery News
    • Dietary Supplements News
    • Supplier News
    • Health & Beauty Aid News
    • Green News
    • Research
  • Features
    • Supplements
    • Grocery
    • Health & Beauty Aids
    • Suppliers
  • Columns
    • Debates
    • Editorial
    • Good Health Reads
    • Happy Customer
    • Herb of the Month
    • Leadership Profiles
    • Legal Tips
    • Mentors
    • Merchandising Insights
    • Recipes
    • Naturally Informed Education
    • The Nutrition Mythbuster
    • Trade Secrets
    • Vitamin Connection
    • What's Selling
    • WholeFoods Blogs
  • Products
    • Dietary Supplements
    • Grocery Products
    • Gourmet Products
    • Health & Beauty Aid Products
    • New Product Reviews
      • 2021 Archives
      • 2019 Archives
      • 2018 Archives
    • Suppliers
  • Multimedia
    • Videos
    • Podcast
    • The Natural View
  • Directory
Ask WholeFoods Mag
  • Log In
  • Register
  • Log Out
  • My Account
Free Newsletter Subscription
Quicklinks
  • Ask Whole Foods Mag
  • Magazine Subscription
  • View Back Issues
  • Advertise
  • Education Center
  • Ashwagandha / Shatavari Experience
  • Naturally Informed
  • Move Nutrition
  • India-America Boardroom Series
Home » Keywords » standardized ashwagandha extract clinical study

Items Tagged with 'standardized ashwagandha extract clinical study'

ARTICLES

Ashwagandha root extract alongside ashwagandha roots, representing new clinical research evaluating the safety of a 2,000 mg daily dose in healthy adults.

Study Finds KSM-66 Ashwagandha Safe and Well Tolerated at 2,000-mg Daily Over 12 Weeks

A newly published clinical study found that 2,000 mg per day of KSM-66 Ashwagandha—more than three times the commonly studied 600 mg dose—was well tolerated, with no clinically significant changes observed in liver, kidney, or thyroid function markers.
June 9, 2026
WholeFoods Magazine Staff

A new clinical trial published in Frontiers in Nutrition reports that 2,000 mg daily of KSM-66 Ashwagandha was well tolerated over 12 weeks, with no clinically significant changes in liver, kidney, or thyroid function markers.



Read More
Recommended For You
Latest Publication
Screenshot_2026-05-26_at_7.47.16_AM.jpg
June/July 2026
CovHeart.jpg
2026 Deep Dive Cardiovascular Health
Screenshot_2026-04-16_at_11.51.39_AM.png
May 2026
CovMi26.jpg
2026 Mastering the Microbiome Market
Most Popular
  • DOP Venkat8707T01.JPG

    KSM-66 Ashwagandha/Shatavari Experience: Explore Shatavari

    By WholeFoods Magazine Contributor
    June 9, 2026
  • Fostering mental wellness.

    The Pillars of Mental Resilience

    By Jennifer Joseph
    June 1, 2026
  • GettyImages-1356683353.jpg

    In Memoriam: John James Mastel Sr., Founder of Mastel's Health Foods

    By Richard Ortega, Associate Editor, WholeFoods Magazine
    June 9, 2026

WholeFoods Magazine is your one-stop resource for health and nutrition articles. We provide important information regarding industry news, research, and trends.

The Magazine

  • Current Issue
  • Subscribe
  • Renew
  • Change of Address

Information

  • Source Directory
  • Helpful Resources
  • Job Finder

About Us

  • About Us
  • Contact Us
  • Advertise

Social

NOTE: WholeFoods Magazine is a business-to-business publication. Information on this site should not be considered medical advice or a way to diagnose or treat any disease or illness. Always seek the advice of a medical professional before making lifestyle changes, including taking a dietary supplement. The opinions expressed by contributors and experts quoted in articles are not necessarily those of the publisher or editors of WholeFoods.

© Copyright 2026 WFC, Inc. All Rights Reserved.
Privacy PolicyTerms